Order Article Reprints

Xu L, Wang J, Liu B, Fu J, Zhao Y, Yu S, Shen L, Yan X, Su J. HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition. Biomedicines. 2022; 10(2):374. https://doi.org/10.3390/biomedicines10020374

Xu, Long, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, and Jing Su. 2022. "HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition" Biomedicines 10, no. 2: 374. https://doi.org/10.3390/biomedicines10020374

Xu, L., Wang, J., Liu, B., Fu, J., Zhao, Y., Yu, S., Shen, L., Yan, X., & Su, J. (2022). HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition. Biomedicines, 10(2), 374. https://doi.org/10.3390/biomedicines10020374